4.6 Article

Valproate activates the Snf1 kinase in Saccharomyces cerevisiae by decreasing the cytosolic pH

期刊

JOURNAL OF BIOLOGICAL CHEMISTRY
卷 297, 期 4, 页码 -

出版社

ELSEVIER
DOI: 10.1016/j.jbc.2021.101110

关键词

-

资金

  1. National Institutes of Health [R01 GM125082, R01 GM126020]

向作者/读者索取更多资源

The study found that valproate affects cellular metabolism in yeast by modulating cytosolic pH, leading to increased expression of metabolic genes. These results reveal a central role for pH in regulating the metabolic program of yeast cells.
Valproate (VPA) is a widely used mood stabilizer, but its therapeutic mechanism of action is not understood. This knowledge gap hinders the development of more effective drugs with fewer side effects. Using the yeast model to elucidate the effects of VPA on cellular metabolism, we determined that the drug upregulated expression of genes normally repressed during logarithmic growth on glucose medium and increased levels of activated (phosphorylated) Snf1 kinase, the major metabolic regulator of these genes. VPA also decreased the cytosolic pH (pHc) and reduced glycolytic production of 2/3-phosphoglycerate. ATP levels and mitochondrial membrane potential were increased, and glucose-mediated extra cellular acidification decreased in the presence of the drug, as indicated by a smaller glucose-induced shift in pH, suggesting that the major P-type proton pump Pma1 was inhibited. Interestingly, decreasing the pHc by omeprazole-mediated inhibition of Pma1 led to Snf1 activation. We propose a model whereby VPA lowers the pHc causing a decrease in glycolytic flux. In response, Pma1 is inhibited and Snf1 is activated, resulting in increased expression of normally repressed metabolic genes. These findings suggest a central role for pHc in regulating the metabolic program of yeast cells.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据